Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹152.34
Market cap
₹2,388 Cr
Revenue (annual)
₹2,932 Cr
Net profit (annual)
₹97.45 Cr
P/E (TTM)
147.8×Sector 47.4×
Promoter holding
59.32%+0.00% QoQ
FII holding
6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:08 IST BSE
Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis Ltd submitted a statement confirming the utilization of proceeds from non-convertible debt securities issued on June 9, 2026, with no deviations.

15:58 IST BSE
Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis Ltd filed its quarterly shareholding pattern for the quarter ended June 30, 2026. The disclosure includes notes regarding promoter group changes and SBO details.

13:29 IST BSE
Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis submitted its Annual Secretarial Compliance Report for FY2026. The report by Ashok P. Pathak & Co. confirms general regulatory compliance with minor procedural observations.

19:33 IST NSE
Other Announcement

Dishman Carbogen Amcis Other Announcement

Dishman Carbogen Amcis' wholly-owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., successfully completed an unannounced GMP inspection by China's NMPA on April 14, 2026. The inspection of the Shanghai API facility concluded with no observations. This confirms the site's compliance with international regulatory standards and supports the company's growth in China.